Conjunto Clínico Nacional Conclina C.A. (Hospital Metropolitano)

What it is

Conclina is an Ecuadorian healthcare group based in Quito that owns Hospital Metropolitano — the largest private hospital in the country — along with Humana S.A., Ecuador’s third-largest prepaid health plan, and Metrored, a network of ambulatory clinics and telemedicine services.

The flagship hospital positions itself as the most complete and modern medical complex in Ecuador, built to international standards and — since 2011 — the only hospital in the country accredited by Joint Commission International (JCI), the global benchmark for hospital quality.

Beyond the hospital itself, the group holds majority positions in Humana (prepaid insurance) and Centro Médico Metroambulant S.A., which operates the Metrored brand of ambulatory centres. The combination — insurer plus hospital plus clinics — is the same integrated model used by Kaiser Permanente in the United States.

Who owns it

When the American hospital chain AMI withdrew from operations outside the United States and could not find a buyer for its Metropolitano shares, it donated them to Fundación Metrofraternidad — with two conditions: protect the hospital’s quality, and use dividends from the group to fund free care for people with fewer resources.

Metrofraternidad, a non-profit foundation created in 1986, is therefore the controlling shareholder today. A minority of shares is publicly listed and has traded on the Bolsa de Valores de Quito; in the first half of 2021, the share changed hands 18 times at a price of essentially $1.00.

The exact ownership split between Metrofraternidad and free-float shareholders is not published in accessible filings.

Who runs it

Javier Contreras is both the CEO (Presidente Ejecutivo) of the Grupo Conclina and the General Manager of Hospital Metropolitano. He holds an MBA and postgraduate degrees in marketing, data analytics, and healthcare management.

Mauricio Rodríguez serves as the group’s Chief Financial Officer (Director Financiero). Cecilia de Páez, longest-serving senior manager in the company, is President of Fundación Metrofraternidad, the controlling shareholder entity.

The money, in plain words

Not published: Conclina’s audited revenue, net profit, net margin, return on equity, and price-to-earnings ratio are not available in open access. The Superintendencia de Compañías, Valores y Seguros (SCVS) portal at mercadodevalores.supercias.gob.ec holds the company’s securities-market filings behind an authenticated login; the BVQ does not publish issuer financials freely; and commercial aggregators (EMIS) hold the data behind a paywall.

Under Ecuador’s Ley de Mercado de Valores, companies with publicly listed shares are required to file audited annual financial statements with the SCVS — those statements exist, but are not freely downloadable by the public from the portal visited for this report.

The one verified reference point: CEO Javier Contreras stated in the IFC/World Bank case study that, at the time of the group’s first IFC investment (2015), revenues “surpassed $100 million a year.” In an October 2023 interview, Contreras noted that Humana alone had tripled in size over the prior six years and now serves a base of 210,000 members. Group revenue today is almost certainly materially above the 2015 figure, but no audited number is publicly available.

What it is doing now

As of late 2023, Conclina was planning to open a satellite hospital in Cumbayá — a fast-growing valley district of Quito — while simultaneously expanding Metrored, having opened three new ambulatory centres in Quito and Guayaquil in the prior 18 months.

The group’s continued expansion is tied to its partnership with IFC (the World Bank’s private-sector arm), which requires environmental commitments and strong corporate-governance practices as conditions of financing. Conclina has also reached an internal milestone: 80% of its corporate management roles are now held by women.

What to watch

• Satellite hospital: The planned Cumbayá campus would be the group’s first full hospital outside its main Quito site — a test of whether the JCI-quality model can scale without diluting standards or margins.
• Financial transparency: Conclina’s audited financials are filed with the SCVS but not publicly accessible online. Any move to improve disclosure — or a secondary capital raise on the BVQ — would be the clearest signal of institutional maturity.
• Humana’s growth engine: The prepaid health business, now at 210,000 members, is the fastest-growing piece. If Ecuador’s private insurance penetration rises, Humana is the most obvious value driver in the group.
• IFC relationship: Two successive IFC financings (2015 equity, 2020 credit line) show the group’s appetite for long-term institutional capital. A third transaction — or a repayment event — would reprice the group’s cost of money and reveal how the balance sheet has evolved.

This is news, not investment advice.